Pfizer Acquires Rare Disease Specialist Therachon

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 5 (Table of Contents)

Published: 14 May-2019

DOI: 10.3833/pdr.v2019.i5.2422     ISSN: 1756-7874

Section: Mergers & Acquisitions



Adding to its growing rare disease pipeline, Pfizer has agreed to acquire Therachon for a total deal value of US$810 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details